ABSTRACT
BACKGROUND: Niemann-Pick disease Type C (NP-C) is a genetic lipid storage disorder characterised by progressive neurovisceral symptomatology. Typically, disease progression is more pronounced in patients with early onset of neurological symptoms. Heterogeneous clinical presentation may hinder disease recognition and lead to delays in diagnosis. Here we describe the prevalence of signs and symptoms observed in patients with NP-C and analyse the relationship between these symptoms in different age groups. METHODS: The combined patient cohort used in the analyses comprised NP-C cases (n=164) and controls (n=135) aged 0 to 60years from two previously published cohorts; a cohort of all ages from which patients ≤4years of age were excluded and a cohort with early-onset NP-C and age-matched controls. The analysis of relationships between different signs and symptoms was performed for both NP-C cases and controls in two sub-groups, ≤4 and >4years of age, using cluster analyses. The threshold of 4years of age was selected to reflect the minimum age cut-off for satisfactory discriminatory power of the original NP-C SI. To assess the prevalence of individual signs and symptoms at age of diagnosis, patients were categorised by age into 5-year sub-groups, and prevalence values estimated for each sign and symptom of NP-C. RESULTS: Two main clusters of symptoms were clearly defined for NP-C cases in each age sub-group, whereas clusters were not as clearly defined for controls. For NP-C cases ≤4years of age, one cluster comprised exclusively visceral symptoms; the second cluster combined all other signs and symptoms in this age group. For NP-C cases >4years of age, each cluster contained a mixture of visceral, neurological and psychiatric items. Prevalence estimations showed that visceral symptoms (e.g. isolated unexplained splenomegaly) were most common in NP-C cases ≤4years of age. Neurological symptoms were generally more common in NP-C cases >4years of age than in younger patients, with the exception of hypotonia and delayed developmental milestones. CONCLUSIONS: These analyses provide a comprehensive overview of symptomatology observed in a large combined cohort of patients with NP-C and controls across a wide range of ages. The results largely reflect observations from clinical practice and support the importance of multi-disciplinary approaches for identification of patients with NP-C, taking into account age-specific manifestations and their possible correlations.
Subject(s)
Mental Disorders/epidemiology , Nervous System Diseases/epidemiology , Niemann-Pick Disease, Type C/pathology , Splenomegaly/epidemiology , Viscera/pathology , Adolescent , Adult , Age Factors , Age of Onset , Child , Child, Preschool , Cluster Analysis , Disease Progression , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Niemann-Pick Disease, Type C/complications , Prevalence , Young AdultABSTRACT
BACKGROUND: Niemann-Pick disease Type C (NP-C) is difficult to diagnose due to heterogeneous and nonspecific clinical presentation. The NP-C Suspicion Index (SI) was developed to identify patients with a high likelihood of NP-C; however, it was less reliable in patients aged <4 years. METHODS: An early-onset NP-C SI was constructed following retrospective chart review of symptom presentation in 200 patients from nine centres comprised of 106 NP-C cases, 31 non-cases and 63 controls. Statistical analyses defined strength of association between symptoms and a diagnosis of NP-C and assigned risk prediction scores to each symptom. RESULTS: Visceral symptoms were amongst the strongest predictors. Except for gelastic cataplexy and vertical supranuclear gaze palsy, central nervous system symptoms were not discriminatory in this population. Performance of the early-onset NP-C SI was superior versus the original NP-C SI in patients aged ≤4 years. CONCLUSIONS: The early-onset NP-C SI can help physicians, especially those with limited knowledge of NP-C, to identify patients aged ≤4 years who warrant further investigation for NP-C.
Subject(s)
Decision Support Techniques , Health Status Indicators , Niemann-Pick Disease, Type C/diagnosis , Age Factors , Case-Control Studies , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Logistic Models , Male , Retrospective Studies , Risk Assessment , Sensitivity and SpecificityABSTRACT
OBJECTIVE: To identify nailfold videocapillaroscopic features and other clinical risk factors for new digital ulcers (DUs) during a 6-month period in patients with systemic sclerosis (SSc). METHODS: In this multicenter, prospective, observational cohort study, the videoCAPillaroscopy (CAP) study, we evaluated 623 patients with SSc from 59 centers (14 countries). Patients were stratified into 2 groups: a DU history group and a no DU history group. At enrollment, patients underwent detailed nailfold videocapillaroscopic evaluation and assessment of demographic characteristics, DU status, and clinical and SSc characteristics. Risk factors for developing new DUs were assessed using univariable and multivariable logistic regression (MLR) analyses. RESULTS: Of the 468 patients in the DU history group (mean ± SD age 54.0 ± 13.7 years), 79.5% were female, 59.8% had limited cutaneous SSc, and 22% developed a new DU during follow-up. The strongest risk factors for new DUs identified by MLR in the DU history group included the mean number of capillaries per millimeter in the middle finger of the dominant hand, the number of DUs (categorized as 0, 1, 2, or ≥3), and the presence of critical digital ischemia. The receiver operating characteristic (ROC) of the area under the curve (AUC) of the final MLR model was 0.738 (95% confidence interval [95% CI] 0.681-0.795). Internal validation through bootstrap generated a ROC AUC of 0.633 (95% CI 0.510-0.756). CONCLUSION: This international prospective study, which included detailed nailfold videocapillaroscopic evaluation and extensive clinical characterization of patients with SSc, identified the mean number of capillaries per millimeter in the middle finger of the dominant hand, the number of DUs at enrollment, and the presence of critical digital ischemia at enrollment as risk factors for the development of new DUs.
Subject(s)
Fingers , Microscopic Angioscopy , Peripheral Vascular Diseases/epidemiology , Scleroderma, Systemic/diagnostic imaging , Skin Ulcer/epidemiology , Adult , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Peripheral Vascular Diseases/diagnostic imaging , Peripheral Vascular Diseases/etiology , Peripheral Vascular Diseases/physiopathology , Prospective Studies , ROC Curve , Risk Factors , Scleroderma, Limited/complications , Scleroderma, Limited/diagnostic imaging , Scleroderma, Systemic/complications , Skin Ulcer/diagnostic imaging , Skin Ulcer/etiology , Skin Ulcer/physiopathologyABSTRACT
La utilidad del uso intraperitoneal de la lidocaína, es evaluada en un ensayo clínico doble ciego, aleatorio, en 97 pacientes (88 del sexo femenino y 9 del sexo masculino), con clasificación ASA I-II, quienes fueron sometidos a laparotomía o laparoscopia electivas diagnósticas u operatorias. Los pacientes se distribuyeron en 3 grupos: Grupo I, que recibió lidocaína al 2 por ciento sin epinefrina a una dosis de 3 mg/kg, administrado dentro de la cavidad abdominal. Grupo II, al que le administró lidocaína peritoneal 6mg/kg. Grupo III, de control, a quienes no se les administró medicamento alguno en el peritoneo. Se evaluó el dolor postoperatorio inmediato, a la hora y a las dos horas, mediante la escala visual análoga (VAS), encontrando una mejor analgesia en los pacientes de los grupos I y II con respecto al control, diferencia estadísticamente significativa. Se realiza un análisis teórico que respalda los resultados obtenidos
